InterMune (ITMN) Jumps: Stock Rises 9.5% - Tale of the Tape
January 10 2014 - 7:57AM
Zacks
InterMune Inc.
(ITMN) was a big mover last session, as the company saw its shares
rise over 9% on the day. The move came on solid volume too with far
more shares changing hands than in a normal session. This continues
the recent uptrend for the company since Dec 19.
The company has seen no estimate revision over the past 30 days and
the Zacks Consensus Estimate has not been in a trend either.
Yesterday’s price jump is encouraging though, so make sure to keep
a close watch on this firm in the near future.
InterMune currently has a Zacks Rank #3 (Hold) while its Earnings
ESP is 0.00%.
However, better-ranked stocks in the medicine-biomedicine gene
industry include Affymetrix Inc.
(AFFX), Genomic Health Inc.
(GHDX) and Neuralstem, Inc.
(CUR). While Affymetrix and Gentium sport a
Zacks Rank #1 (Strong Buy), Neuralstem has a Zacks Rank #2
(Buy).
Want the latest recommendations from Zacks Investment Research?
Today, you can download 7 Best Stocks for the Next 30
Days. Click to get this free report >>
AFFYMETRIX INC (AFFX): Free Stock Analysis Report
GENTIUM SPA-ADR (GENT): Free Stock Analysis Report
GENOMIC HEALTH (GHDX): Free Stock Analysis Report
INTERMUNE INC (ITMN): Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
Affymetrix (NASDAQ:AFFX)
Historical Stock Chart
From Sep 2024 to Oct 2024
Affymetrix (NASDAQ:AFFX)
Historical Stock Chart
From Oct 2023 to Oct 2024
Real-Time news about Affymetrix, Inc. (NASDAQ): 0 recent articles
More Affymetrix News Articles